EFOR Group
Premium PartnerIs this your company? Claim this profile
Regulatory, Tech Transfer & Support Services
Company Overview
About
EFOR Group is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2003
Employees:2,903
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Regulatory Approvals
Drug Approval HRWL9H
Health Canada · #APR-9H87684L · 2018-01-01
Drug Approval XNMW1K
Health Canada · #APR-R3ZET6FH · 2019-11-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-FR0QG3UH
Issued: 2020-06-26
Expires: 2025-04-07
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-3KAV2TJP
Issued: 2020-06-10
Expires: 2025-02-09
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-5VOFAFTF
Issued: 2020-02-20
Expires: 2025-12-13
Loading CDMO intelligence...
Key facts about EFOR Group
- EFOR Group is headquartered in France.
- EFOR Group was founded in 2003.
- EFOR Group has 2,903 employees.
- EFOR Group's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like EFOR Group
Directory pages this company appears in, each with the full list of matching manufacturers.